Claritev Corporation
CTEV
Positions held
Your positionsCTEV isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $412.33M | Enterprise value | $5.10B | Trailing P/E | — | Forward P/E | 3.32 |
| PEG | — | Price / book | -1.40 | Beta | 0.94 | Dividend yield | 0.00% |
| Revenue growth | 6.6% | Earnings growth | — | Gross margin | 73.0% | Operating margin | 12.8% |
| Profit margin | -28.5% | ROE | — | ROA | 1.2% | Debt / equity | — |
| Current ratio | 1.00 | Free cash flow | $102.99M | Analyst recommendation | buy | Mean target | $46.00 |
| 52w high | $73.68 | 52w low | $11.50 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $257M | $245M | $247M | $246M | $242M | — |
| Op margin | 12.8% | 7.5% | 21.7% | 4.1% | 10.9% | — |
| Net income | -$59.2M | -$73.6M | -$80.6M | -$69.8M | -$62.6M | — |
| Gross margin | 67.3% | 67.0% | 68.4% | 66.5% | 67.2% | — |
| Gross profit | $173M | $164M | $169M | $164M | $162M | — |
| Operating income | $33.0M | $18.5M | $53.6M | $10.1M | $26.3M | — |
- Revenue +5% vs prior quarter ($257M vs $245M).
- Gross margin 67.3% (was 67% prior quarter).
- Operating margin expanded to 12.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $965M | $931M | $962M | $1.1B |
| Op margin | 9.3% | 11.6% | 17.8% | 31.0% |
| Net income | -$284M | -$1.6B | -$91.7M | -$573M |
| Gross margin | 67.2% | 67.4% | 69.3% | 81.1% |
| Gross profit | $649M | $627M | $666M | $876M |
| Operating income | $90.0M | $108M | $171M | $334M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-22 · Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
2026-09-17 · Claritev Releases 2025 Corporate Responsibility Report
2026-09-15 · Claritev Appoints Ben Letham to its Board of Directors
2026-09-10 · Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
2026-09-08 · Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks
2026-08-27 · Claritev Corporation Announces Participation in Upcoming Events
2026-08-17 · Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
2026-08-14 · Claritev (CTEV) Q2 2026 Earnings Call Transcript
2026-08-14 · Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks
2026-08-12 · Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing
2026-08-08 · Claritev Corporation Q2 2026 Earnings Call Summary
2026-08-08 · Claritev Q2 Earnings Call Highlights
Price (daily)
Full chart · RSI · MACD · patterns